Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsCNBC • 05/21/24
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 05/15/24
Novo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.The Motley Fool • 05/15/24
Weight loss wonder drug reduces chance of heart attack and stroke by a fifthProactive Investors • 05/14/24
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trialGlobeNewsWire • 05/13/24
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive' U.S. Drug PricesForbes • 05/13/24
Novo Nordisk weight loss rollout to prompt ‘dramatic upgrades' - analystsProactive Investors • 05/13/24